Loading...
•
Mar 31, 2024
Amedisys Q1 2024 Earnings Report
Amedisys reported financial results for Q1 2024, showing increased net service revenue but decreased net income compared to the previous year. Adjusted EBITDA and adjusted net income also increased.
Key Takeaways
Amedisys reported a mixed performance for Q1 2024. Net service revenue increased to $571.4 million, but net income decreased to $14.4 million due to merger-related expenses. Adjusted EBITDA and adjusted net income showed improvements compared to Q1 2023.
Net service revenue increased by $15.0 million to $571.4 million compared to Q1 2023.
Net income attributable to Amedisys, Inc. decreased to $14.4 million, inclusive of $20.7 million in merger-related expenses.
Adjusted EBITDA increased to $59.9 million compared to $57.8 million in Q1 2023.
Adjusted net income attributable to Amedisys, Inc. increased to $33.9 million compared to $32.7 million in Q1 2023.
Forward Guidance
Amedisys has a pending merger with UnitedHealth Group Incorporated and will not conduct a quarterly earnings call.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...